Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02218203 · ClinicalTrials.gov registry record · Phase 2

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial

A Phase 2 study of Spinal Cord Injury and Central Neuropathic Pain, sponsored by Brigham and Women's Hospital.

Completed
Registry status
Phase 2
Development phase
26
Enrollment target
1
Study location

NCT02218203 is a Phase 2 study of Spinal Cord Injury and Central Neuropathic Pain that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 26 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02218203, a Phase 2 study of Spinal Cord Injury and Central Neuropathic Pain, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
Phase 2
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

This randomized, placebo-controlled, double-blind 4x4 crossover clinical trial was part of a larger NIH-funded study to evaluate the analgesic efficacy of multiple dose-combinations of chronic oral (PO) dextromethorphan and intravenous (IV) lidocaine in central neuropathic pain following spinal cord injury.

Conditions Studied

Spinal Cord Injury Central Neuropathic Pain Allodynia

Interventions

  • DRUG Lidocaine
  • DRUG Dextromethorphan
  • DRUG Placebo (Dextromethorphan)
  • DRUG Placebo (Lidocaine)

Study Locations (1)

Massachusetts

  • Translational Pain Research, Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2003-04
Est. Completion 2008-01
Phase Phase 2

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02218203

The ClinicalTrials.gov registry entry for NCT02218203 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (70% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 4 interventions - of which Lidocaine is the first listed.

NCT02218203 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02218203 about?

NCT02218203 is a clinical study titled "Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial". This randomized, placebo-controlled, double-blind 4x4 crossover clinical trial was part of a larger NIH-funded study to evaluate the analgesic efficacy of multiple dose-combinations of chronic oral (PO) dextromethorphan and intravenous (IV) lidocaine in central neuropathic pain following spinal cord...

What is the current status of trial NCT02218203?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2003-04. Estimated completion is 2008-01.

What conditions does trial NCT02218203 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Central Neuropathic Pain, Allodynia.

What interventions are being tested in trial NCT02218203?

The interventions under investigation include: Lidocaine (DRUG), Dextromethorphan (DRUG), Placebo (Dextromethorphan) (DRUG), Placebo (Lidocaine) (DRUG).

Who is sponsoring clinical trial NCT02218203?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02218203 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Spinal Cord Injury

All registered trials for this condition

Central Neuropathic Pain

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.